Anna Clarke

Methodologist
Ottawa Hospital Research Institute and ICES

Presentation(s):

• OC 16.2 - Hemorrhage risk in direct oral anticoagulant users receiving tamoxifen for breast cancer versus aromatase inhibitors: The STOP-Bleed Cancer study

  Sunday, July 10, 2022
  11:00 AM – 11:15 AM